Quantcast
Channel: All News Releases
Viewing all articles
Browse latest Browse all 4004

NeuroCytonix Launches Clinical Trial Studying Its NeuroCytotron Protocol for Autism

$
0
0

The NeuroCytotron utilizes non-invasive, safe tissue engineering technology to stimulate proteins that aid in the regeneration of brain cells. ROCKVILLE, Md., July 3, 2024 /PRNewswire-PRWeb/ -- NeuroCytonix, Inc., today announced that on May 27, 2024, its subsidiary NeuroCytonix Mexico...


Viewing all articles
Browse latest Browse all 4004

Trending Articles